Selective immunosuppressants

Xolair 150 mg lyophilized powder for injection Images

Generic Name: omalizumab

This medication has been identified as Xolair 150 mg lyophilized powder for injection. It is supplied by Genentech, Inc.

Xolair is used in the treatment of Urticaria; Nasal Polyps; Asthma, Maintenance and belongs to the drug class selective immunosuppressants. There is no proven risk in humans during pregnancy. Xolair 150 mg lyophilized powder for injection is not a controlled substance under the Controlled Substances Act (CSA).

Images

Xolair (Omalizumab [ oh-ma-liz-oo-mab ])-medicine-150 mg lyophilized powder for injection

Xolair
Generic Name: omalizumab [ oh-ma-liz-oo-mab ]
Imprint: medicine
Strength: 150 mg lyophilized powder for injection
Color: N/A
Size: N/A
Shape: N/A
Availability: Prescription only
Drug Class: Selective immunosuppressants
Pregnancy Category: B - No proven risk in humans
CSA Schedule: Not a controlled drug
Labeler / Supplier: N/A
National Drug Code (NDC): 50242-0040
Inactive Ingredients:
Latest News
Related Drugs